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Summary
CD3-e gene expression is confined to the T cell lineage. We have recently identified and cloned
ahuman transcription factor, TCF-1, that binds to a functional element in theT lymphocyte-specific
enhancer ofCD3-e . In a panel ofhuman cell lines, TCF-1 expression was restricted to T lineage
cells . TCF-1 belonged to a novel family of genes that contain the so-called high mobility group
1 (HMG) box . Herewe report the cloning ofmurine TCF-1 . Two splice alternatives were identified
that were not previously observed inhuman TCF-1 . Murine and humanTCF-1 displayed a 95.5%
overall amino acid homology . Recombinant murine and human TCF-1 recognized the same sequence
motif in the CD3-e enhancer as judged by gel retardation and methylation interference assays .
With the murine cDNA clones several aspects of TCF-1 were analyzed . First, deletion analysis
revealed that a region of TCF-1 containing the HMG box was sufficient for sequence-specific
binding. Second, by high stringency Northern blotting and in situ hybridization, TCF-1 expression
was shown to be confined to the thymus and to the T cell areas of the spleen. Third, TCF-1
bound specifically to a functional T cell-specific element in the T cell receptora (TCRci) enhancer.
The T lineage-specific expression and the affinity for functional motifs in the TCR-a andCD3-e
enhancers imply an important role for TCF-1 in the establishment ofthe matureT cell phenotype .
T
he phenotype of a cell is determined by the complement
of actively transcribed structural genes in that cell . A
differentiating cell proceeds through a program of pheno-
type changes . Unique sets of structural genes are expressed
at each step. Control of the expression of such sets of genes
is exerted principally by developmentally active transcription
factors ; the activation and inactivation of these transcription
factors is believed to be central to the control of phenotype
during differentiation (1-3) .
In recent years, it has become feasible to identify the cis-
acting elements (promoters, enhancers, silencers) that con-
trol transcription of structural genes expressed at particular
stages ofdifferentiation . These cis-acting elements can be used
to identifyDNAbinding transcription factors that recognize
specific sequence motifs within these elements. Of special in-
terest are transcription factors that are uniquely active in the
cell type where the structural gene is expressed . Several so-
called "tissue-specific" transcription factors have thus been
identified and cloned. These include theB lymphocyte factor
Oct-2, which binds the octamer motif(ATTTGCAT) of the
B cell-specific regulatory elements of the Ig genes (4, 5) ; the
pituitary factor Pit-1, which controls growth hormone and
prolactin gene expression in somatotroph and lactotroph cells
respectively (6, 7) ; the erythrocyte factor EryFI, which binds
to hemoglobin regulatory sequences (8, 9) ; andMyoD (and
several related genes), which can confer the muscle cell pheno-
type onto fibroblasts (10, 11) .
The recent identification of a number of T lympho-
cyte-specific enhancers (reviewed in reference 12) allows the
characterization of transcription factors that govern the
differentiation pathway of the T lymphocyte. We have set
out to analyze the T cell-specific enhancer of the gene en-
coding the CD3-e chain of the TCR/CD3 complex (13-15) .
We have recently described and cloned a transcription factor
from human T cells, TCF-1, that is involved in the activity
of this enhancer (16) . TCF-1 was initially detected by gel
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binding to the human CD3-e enhancer. Methylation inter-
ference footprinting revealed that the TCF-1 cognate motif
in the CD3-e enhancer consistedofAAcAAAG (where con-
tact bases are capitalized) . TCF-1 was subsequently cloned
and was found to be a member of a family of genes with
homology to high mobility group I (HMG)' proteins . This
family includes the polymerase I transcription factor UBF
(17), the putativemammaliansex-determining gene SRY(18),
andS . pombe andN . crassa mating type genes (19, 20) . Three
alternative splice forms of the TCF-1 gene were identified
that differed at theextremeCOOH terminus of the encoded
protein . Thesealternative splice forms were termed TCF-1A,
TCF-1B, andTCF-1C . Within apanelofcell lines, theTCF-1
genewas expresseduniquely in T cells. Finally, recombinant
TCF-1 could transactivate transcription through its cognate
motif . Here, we report the isolation and analysis of murine
TCF-1 cDNA clones .
Materials and Methods
Cells.
￿
Human T cell linesJurkat,MoM, and Peer ; themurine
TCR-a//3 T cell line EIr4 ; humanBlineage cell lines BS 4.9 and
Daudi ; andthemurineBlineage line Ag-8 were allgrown in RPMI
1640 supplemented with 5% FCSand antibiotics. Thehuman cer-
vical carcinoma cell line HeLa and murine fibroblasts NIH-3T3
were grrnvn in DMEM supplemented with 5% FCSand antibiotics.
NuclearExtracts.
￿
Nuclear extracts were prepared by gentle lysis
of 107-108 cells in lysis buffer (30% sucrose [wt/vol] ; 40 mM Tris
[pH 7.5] ; 37 mM KCI; 12MM MgC1 2) in the presence of 0.8%
Triton X-100. After two washes with lysis buffer, the nuclei were
extracted with 2.5 pellet volumes ofextraction buffer (10mM Hepes
[pH 7.9] ; 400mM NaCl ; 1.5 MM MgC12; 0.2 mM EGTA; 20%
glycerol) for 30 min on ice. Nuclear debris was removed by cen-
trifugation (15,000rpm ; 5min) . Protein concentration ofthe clear
supernatant was determined and nuclear extracts were stored at
-70°C .
Gel Retardation Assay.
￿
Annealed oligonucleotides were labeled
by T4 polynucleotide kinase and r-1 32p]-ATP. All probes were
purified by polyacrylamide electrophoresis . For a typical binding
reaction, nuclear extract (5 hg protein) and 1 i~g poly dI-dC were
incubated in avolume of 15 ul containing 10mM Hepes, 60 mM
KCI, 1 mM EDTA, 1mM IYTT, and 12% glycerol . After 5 min
of preincubation at room temperature, a probe (20,000 cpm) was
added and the mixture was incubated for an additional 20 min.
The sampleswere then subjected to electrophoresis through a non-
denaturing4% polyacrylamide gel run in 0.25 * TBE at room tem-
perature. In competition experiments, nonlabeled competitorDNA
was added with the poly dI-dC.
Probes Used.
￿
MWel (identical to MW56 in reference 16) :GGG
AGACTGAGAACAAAGCGCTCTCACAC annealed to CCCGTG-
TGAGAGCGCTTTGTTCTCAGTCT. MWelSac : GGGAGACTG-
AGCCGCGGTCGCTCTCACAC annealed to CCCGTGTGAGA
GCGACCGCGGCTCAGTCT MWelAlG : GGGAGACTGG-
GAACAAAGCGCTCTCACAC annealed to CCCGTGTGAG-
AGCGCTTTGTTCCCAGTCT MWSB: GGGTAATTAAAAAT
AAAGAACATGAT annealed toCCCATCATGTTCTTTATTTT
TAATTA . MWpal: GGGCCCCCTCTGCAAGCAGAGTGT an-
nealed to GGGACACTCTGCTTGCAGAGGGGG . MWTCF-la:
'Abbreviation used in this paper . HMG, high mobility group.
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GGGCAAGTAGGGCACCCTTTGAAGCTCT annealed to CCC-
AGAGCTTCAAAGGGTGCCCTACTTG. All oligonucleotides
were synthesized on a cell synthesizer (381A ; Applied Biosystems,
Inc., Foster City, CA) .
Isolation ofcDNA Clones.
￿
Murine TCF-1 cDNA clones were
isolated from an EIr4cDNA library in -ZAP (106 primary recom-
binant phages ; average insert size, 1.2 kb) by standard hybridiza-
tion screening at low stringency using the insert of I~TCF-1 (16)
as the probe (21) .
DNA Sequencing . Sequencing was performed on double-
stranded DNA templates using T7 DNA polymerase according
to the manufacturer's instructions (Pharmacia Fine Chemicals, Pis-
cataway, NJ) . Sequencing templateswere generated by subcloning
the inserts of isolated cDNA clones, and BA131 deletions thereof
into pUC19 . Sequencing primers were the universal and reverse
M13 primers, and oligonucleotides representing specific internal
sequences of the cDNA clones .
RNA Isolation and Analysis.
￿
TotalRNA was prepared by cell
lysis in RNAzol according to the manufacturer's instructions
(Cinna-Biotecx), followed by phenol-chloroform extraction and
2-propanol precipitation . 10 Fig of total RNA per lane was run
forNorthern analysis on 1% agarose containing6% formaldehyde.
RNA was transferred to nitrocellulose and hybridized with mu-
rine TCF-1 cDNA probes labeled by random oligo priming, all
according to standard procedures (21) .
In Situ Hybridization .
￿
In situ hybridizationon paraffin-embedded
thymus and spleen sections (2-wk-old male BALB/c)was performed
essentially as described by Wilkinson et al . (22), with modifica-
tions introduced by Kress et al . (23) . An antisense 'IS-labeled
RNA TCF-1 probewas generated using T7 RNA polymerase and
JSS-UTP Template was prepared by subcloning the insert of pM2a
into the EcoR1 site of pBluescript SK (Stratagene); the resulting
construct was digested with Nsil (site at by 941) to yield an ti750-bp
uniformly labeled probe covering 3' untranslated and65 by of coding
sequence of alternative splice form B. This probe did not cross-
hybridize to sequences other than TCF-1 in thehuman and mouse
genome under conditions ofreduced stringency (data not shown) .
Furthermore, as predicted from the structure of the human TCF-1
gene, this probe represented sequences present in all alternative
TCF-1mRNA species.Theprobe size was reduced to 200-300 by
by limited hydrolysis in NaOH .
Expression of Murine 'IUF--1 in Escherichia coli.
￿
E. coli strain
N4830-1 was used as the host for expression of TCF-1 using the
heat-inducible protein A expression vector pRIT2T (24) . 100 ml
of LB containing 100 itg/ml ampicillin was inoculated with 1 ml
of an overnight culture, and grown at 30°C to A6w -0.9 . One
volume LB of 54°C was added and the cells were grown at 42°C
for 90 min . Cells were collected by centrifugation at 5,000 rpm
for 10 min, and the pellet was resuspended in 5 ml of PBS con-
taining 1mM PMSF. The bacteria were lysed by sonification (four
times for4 min) on ice. Cell fragments were removedby centrifu-
gation (10 min at 15,000 g) . The fusion protein was purified over
IgG-Sepharose according to the manufacturer's instructions (Phar-
macia Fine Chemicals) and stored at -70°C . All fusion protein
batches were analyzed by SDS/polyacrylamide gel electrophoresis.
Constructs used were : (a) pRITM2a, generated from pRIT
TCF-lA (16) by digestion with PstI and insertion of the Pstl frag-
ment ofpM2a (bp 586-1121) . (b) 3' deletion clones were generated
by openingpRITM2a at the Nsil site (bp 941), followed by limited
digestionwith Ba131 exonuclease, and insertion ofan oligonucleo-
tide linker containing stop codons in all frames . (c) 5' deletions
were generated by insertion of the Pstl fragment of pM2a (bp
586-1121) intopRIT2T (24), resulting in a 5' truncation, startingat amino acid 133); and insertion of a fragment, generated from
pM2a by PCR, into Smal/Pstl-digested pRIT2T, resulting in a
truncation starting at amino acid 155 . All constructs were sequenced
to determine the deletion start/end points and to exclude PCR
errors .
Methylation Interference Footprinting .
￿
MWel was labeled at the
positive strand oligonucleotide with 7--["P]-ATP using T4 poly-
nucleotide kinase. After annealing, the probewas purified over poly-
acrylamide. The labeled probe was partially methylated at purine
residues using dimethylsulfate . 100,000 cpmof methylated probe
wasused in a scale-up ofthe gel retardation binding reaction . After
fractionation by gel retardation assay, the wet gel was subjected
to autoradiography. The bound and free probes were cut out and
recovered by electroelution . After cleavage by NaOH at G andA
residues, the sequence was analyzed on a10% polyacrylamide-8M
urea sequencing gel.
Results
Gel Retardation Analysis Indicates the Existence ofa Murine
TCR1 Homologue. To demonstrate the presence of a TCF-
1-like binding activity in nuclear extracts from murine T cells,
we performed gel retardation analysis with probe MWel
(which contains the cognate motif ofhuman TCF-1) . Anal-
ysis of nuclear extracts derived from a panel of murine cells
resulted in the appearance of a retarded band that displayed
the same sequence preference and T cell specificity as was
observed withTCF-1 in humanT cell extracts. Fig. 1 depicts
typical results obtained with extracts from the murine thy-
moma cell line El-4, the murine B lineage cell line Ag-8,
and murine NIH-3T3 fibroblasts, as compared with extracts
of several humanT and non-T cell lines. The TCF-1 retarda-
tion band is indicated with a solid arrow. No TCF-1-like
binding was observed with probe MWe1Sac, in which the
AAcAAAG motif is replaced by CCGCGGT (data not
shown) .
Cloning ofMurine TCF--1 .
￿
A X-ZAP cDNA library was
then prepared from the murine TCR/CD3 + EL4 thymoma
cell line (106 primary recombinant phages, average insert
size, 1.2 kb) and amplified . 106 plaques were plated out and
screened with the radiolabeled insert of(PTCF-1, the original
human TCF-1 bacteriophage clone (16) . 10 positive plaques
were isolated . The phages could be divided into two groups
based on restriction digests of their inserts. The inserts of
two representative phages, 4)M2a and IM5, were subcloned
inpUC19, and the resulting plasmids (pM2a andpM5) were
sequenced .
Fig . 2 A depicts the sequence of the insert ofpM2a . By
comparison with the human TCF-1 sequence, pM2a appeared
to encode a full-length version of the TCF-1 protein, with
aCOOH terminus of the TCF-1B splice form (16) . Overall
sequence homology with human TCF-1B was 95.5% at the
amino acid level (see Fig . 2 C) . An in-frame stop codon (bp
13) was present upstream from the first in-frame ATG (bp
190) and is indicated by a solid bar. Comparison of the se-
quence of pM2a and pM5 revealed the presence of an extra
stretch of 93 by inpM2a starting at position 489 (Fig . 2 A) .
This stretch was inserted into the proline-rich domain ofTCF-1
and itself encoded a proline-rich amino acid sequence (see
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Figure 1.
￿
Identification of a TCF-1-like binding activity in murine T
cells. Gel retardation analysis was performed with the TCF-1 cognate probe
MWel in conjunction with nuclear extracts of various human and mu-
rine T and nonT cells. The solid arrow indicates the position of TCF-1
from human and murine T cells. The open arrow indicates the position
of another (ubiquitous) DNA-binding protein unrelated to TCF-1 . Ex-
tracts were prepared from : human cell lines (left) : lane 1, Jurkat ; lane 2,
Molt4 ; lane 3, Peer ; lane 4, BS 4.9 ; lane 5, Daudi; lane 6, HeLa . Murine
cell lines (right) : lane 7, El-4 ; lane 8, Ag-8 ; lane 9, NIH-3T3 . Lanes 1-3
and 7 are T lineage cells ; lanes 4, 5, and 8 are B lineage cells. HeLa is
a cervical carcinoma cell line. NIH-3T3 is a murine fibroblast cell line .
Fig. 2 B : proline-rich alternative splice) . The site of inser-
tion, marked withP in Fig. 2A, coincided with exon-intron
boundaries in the human TCF-1 gene (M . van de Wetering,
F. Holstege, andH . Clevers, manuscript in preparation), in-
dicating that pM2a represented a genuine alternative splice;
it was not previously encountered among 34 independent
human TCF-1 cDNA clones (16) . From Northern blot anal-
ysis, the principal murine TCF-1 mRNA was estimated to
be -2,900 by (see below) . Thus, pM2a lacked some 1,200
by of 3' untranslated sequence .
The shorter doneM5 represented a splice alternative, which
was termedTCF-1D and whichwe recently also isolated from
human T cells (M.W. andH . Clevers, unpublished results) .
As compared with M2a, 23 by were inserted near the COON
terminus of the encoded protein (marked withD in Fig. 2
A) . The sequence of this stretch is given in Fig . 2 B . The
presence of a stop codon at by 21 of theD insert predictedgaattccgtgaatgagtccgaaggcgcggccgcagggccggggtcccgggtcccggcgtc 60
cgagtacatggagaagccgagggagcgcccgaggccctgggacgggagcacacttcgcag 120
agacttttcccggacaaacttccagagtccctagaggacggcctgaaggccccggagtgt 180
gccagtggcATGTACAAAGAGACTGTCTACTCTGCCTTCAATCTGCTCATGCCCTACCCA 240
MetTyrLysGluThrValTyrSerAlaPheAsnLeuLeuMetProTyrPro 17
CCGGCCTCGGGAGCAGGGCAGCATCCGCAGCCTCAACCCCCGCTGCATAACAAGCCCGGC 300
ProAlaSerGlyAlaGlyGlnHisProGlnPrOGlnProProLeuHisAsnLysProGly 37
CAGCCTCCACATGGCGTCCCCCAGCTTTCTCCACTCTACGAACATTTCAGCAGTCCACAC 360
G1nProProHisGlyValProGlnLeuSerProLeuTyrGluHisPheSerSerProHis 57
CCCACCCCTGCACCAGCGGACATCAGCCAGAAGCAAGGAGTTCACAGGCCGCTGCAGACC 420
ProThrProAlaProAlaAspIleSerGlnLysGlnGlyValHisArgProLeuGlnThr 77
CCCGATCTCTCTGGATTTTATTCTCTGACCTCAGGCAGCATGGGACAGCTCCCCCATACT 480
ProAspLeuSerGlyPheTyrSerLeuThrSerGlySerMetGlyGlnLeuProHisThr 97
P
GTGAGCTGGTTCACCCACCCATCCTTGATGCTGGGATCTGGTGTACCTGGACACCCAGCA 540
ValSerTrpPheThrHisProSerLeuMetLeuClySerGlyValProGlyHisProAla 117
GCCATCCCTCACCCGGCCATTGTGCCCTCCTCAGGGAAGCAGGAGCTGCAGCCATATGAT 600
AlalleProHisProAlaIleValProSerSerGlyLysGlnGluLeuGlnProTyrAsp 137
AGAAACCTGAAAACACAGGCAGAACCCAAGGCAGAGAAGGAGGCTAAGAAGCCAGTCATC 660
ArgAsnLeuLysThrGlnAlaGluProLySAlaGluLysGlUAlaLysLysProValIle 157
AAGAAACCCCTCAATGCGTTCATGCTTTACATGAAGGAGATGAGAGCCAAGGTCATTGCT 720
LysLysProLeuAsnAlaPheMetLeuTyrMetLysGluMetArgAlaLysVaIIleAla 177
GAGTGCACACTCAAGGAGAGCGCTGCCATCAACCAGATCCTGGGTCGCAGGTGGCATGCA 780
G1uCysThrLeuLysGluSerAlaAlaIleAsnGlnIleLeuGlyArgArgTrpHisAla 197
CTATCTCGAGAAGAGCAGGCCAAGTACTATGAACTGGCCCGCAAGGAAAGGCAGCTGCAC 840
LeuSerArgGluGluGlnAlaLysTyrTyrGluLeuAlaArgLysGluArgGlnLeuHis 217
ATGCAGCTATACCCGGGCTGGTCCGCGCGGGATAACTACGGAAAGAAGAAGAGGCGGTCA 900
MetGlnLeuTyrProGlyTrpSerAlaArgAspAsnTyrGlyLysLysLysArgArgSer 237
8
AGGGAAAAACATCAAGAATCCACCACAGGAGGAAAAAGAAATGCATTCGGTACTTACCCG 960
ArgGluLysHiSGlnGluSerThrThrGlyGlyLysArgAsnAlaPheGlyThrTyrPro 257
GAGAAGGCCGCTGCCCCAGCCCCGTTCCTTCCGATGACAGTGCTCtaggctgtcccggtc 1020
G1uLysAlaAlaAlaProAlaProPheLeuProMetThrValLeu
￿
272
cccagctccccaggactcaccctcgtatcttctgttgccctccttccccacagaactgct 1080
tgctagcccagtggagccagcaccaacattctcaggtcgctctgcagctctcactcttcc 1140
agcccctaagtctccaaagaccccccacagcaccctccagaatccacagatacagcaaca 1200
agaatctcagagacaggcagectaacagccttggttgctaggcacagaacacctggcttg 1260
ctccaggggcccacccctaactcaggaggaggcaacatgaccagctcccatggaaccagc 1320
taggggtcctcttaaggtgatgaagatttcaaaggctgcacaactccctgaacctggggc 1380
catcaattcaagaggtggggggtctatgtagctgtatcatcttaagggggtcctgccgcc 1440
tctgacagccatatctcttgttattgctggctggacctccctattggcctaggaggtttt 1500
gtttgctgtaggtcagatgggttggactgatctcttcagctgcctaccctacaaatgctt 1560
ctcctgccctctgccacaccctccccatgccaatacttcttggaccaagaatacctggtt 1620
tgtcacacaaaataactctgtggtcaacgggcagcttttgcagccaaaacttcttcagct 1680
ggtccatcaacagcaa
￿
1669
B
Proline-rich alternative splice
a truncated version of the TCF-1 protein . The site of inser-
tion of the D segment coincided with the position where
human TCF-lA/B/C/D alternative splicing occurs. In the
human gene, TCF-1D results from the use of an alternative
splice acceptor site located within the last exon (M . van de
Wetering et al ., manuscript in preparation) .
Recombinant Murine TCF-1 Recognizes the AArAAAG
Motif To investigate the binding specificity ofmurine TCF-1,
we generated a Staphylococcal protein A/TCF-1 fusion pro-
tein using the vector pRIT2T in the appropriate E. coli host
(24) . The fusion protein was purified to near homogeneity
by a single IgG-Sepharose chromatography step. Gel retarda-
tion analysis performed with the purified murine TCF-1B
fusion protein demonstrated specific binding to the MWe1
probe (see Fig. 3A) ; no binding occurred with theMWe1Sac
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Figure 2 .
￿
Sequence ofmurine TCF-1 ; comparison with its human homo-
logue. (A) Composite sequence of pM2a and pM5, excluding the alterna-
tive sequences mentioned in Results . pM2a contained by 1-1615; pM5
contained by 356-1669 . An in-frame stop codon is indicated with a
horizontal bar. (B) The alternative sequences inserted into pM2a (proline-
rich alternative splice ; site ofinsertion indicated withp in A) and in pM5
(COON-terminal alternative splice ; site of insertion with D in A) . (C)
Alignment of the predicted amino acid sequences ofhuman (H) and mu-
rine (114) TCF-1B.
control probe. Subsequent methylation interference foot-
printing revealed that the positive strand contact bases of
recombinant murine TCF-1 were identical to those ofhuman
TCF-1 (indicated by a solid bar in Fig. 3 B) . Under the ex-
perimental conditions, contacts with both A and G appear
as spots of decreased intensity.
The HMG Box of TCF-1 Is Involved in Sequence-specific
Binding. To delineate the domain in TCF-1 that mediates
recognition oftheAAcAAAG motif, a set of deletion clones
of murine TCF-1 was generated in the pRIT2T vector by
Ba131 and PCR techniques. Fusion proteins were purified and
subjected to gel retardation analysis using the cognate probe
MWe1 and the negative control probe MWe1Sac. Fig. 4 sum-
marizes the results obtained with these deletion clones.DNA
binding was confined to the region from amino acid 133 to
--GCCCAGTCCTCCTCTCTACCCCCTGTCCCCTTCCTGCGGATATAGACAGCACTTCCCT 58
TrpProSerProProLeuTyrProLeuSerProSerCysGlyTyrArgGlnHisPhePro
GCCCCCACTGCAGCCCCTGGCGCCCCCTATCCCAG- 93
AlaProThrAlaAlaProGlyAlaProTyrProArg
C-termnal alternative splice (TCF-1D)
-ATAACTCTCTTCACTATTCCtag 23
AspAsnSerLeuHisTyrserFigure 3 .
￿
Recombinant murine TCF-1 binds to the TCF-1 motif in the
CD3-e enhancer. (A) Gel retardation analysis performed with recombinant
murine TCF-1B (M) and human TCF-1A (A) resulted in a specific retarda-
tion band with probe MWel (left, indicated with 56), but not with the
control probe MWe1Sac (right, indicated with 56Sac) . No retarded bands
were observed with control recombinant proteinA (P) . (B) Positive strand
methylation interference footprinting was performed with probeMWel
in conjunction with recombinant murine TCF-iB (M) and human TCF-
lA (A) . Essentially identical footprints were obtained for both proteins
(indicated with a bar, 5'AAcAAAG3') in comparison with the reaction
performed on the free probe (F) . Due to the paucity of purines in the
relevant area of the negative strand of MWel, no contact bases could be
defined by methylation interference on this strand (16) .
237 . This region encompassed the 77-amino acidHMG box
in TCF-1 (amino acids 157-233) as delineated by sequence
comparison with other members of the HMG box family
(16) . It should be noted that a 5' deletion clone starting at
the NH2-terminal boundary (amino acid 155) of the HMG
box did not bindDNA. It thus appeared that residues directly
NH2 terminal to theHMG box (but still located within the
TCF-1 basic domain ; see Fig. 4) were indispensable for cog-
nate interaction with the TCF-1DNA motif. However, we
cannot exclude the possibility that the loss ofbinding resulted
from interference of the protein A fusion segment with an
otherwise intactHMG box in this particular deletion mutant .
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Expression of'ICF-1 Is Confined to the T Cell Lineage.
￿
Low
stringency hybridization has revealed the presence of several
sequences related to TCF-1 in the human and murine ge-
nomes (H. Clevers, unpublished results) . Crosshybridization
to TCF-1-like genes might therefore hamper expression analysis
by Northern blotting at decreased stringency. The availability
of murine cDNA probes allowed examination of TCF-1 ex-
pression in various tissues of the mouse under conditions of
high stringency.
RNA was prepared from 2-wk-old BALB/c mice, and
Northern blotting was performed using a 3' untranslated
TCF-1 probe. A predominant 2 .9-kb mRNA species, com-
parable with the size ofhumanTCF-1 mRNA, was thus ob-
served (see Fig. 5 a) . TCF-1 mRNA was detected only in
thymic and splenic RNA .
To investigate patterns of TCF-1 expression within the
spleen and thymus, we performed in situ hybridization ex-
periments on paraffin-embedded sections of these lymphoid
organs . In situ hybridization of spleen with an antisense 35S-
labeled probe revealed that TCF-1 expression was limited to
the periarteriolar lymphocyte sheaths (PALS), theT cell areas
of the spleen . No signal was observed in red pulp, nor in
the B cell follicles and marginal zone (See Fig. 5 b) . In situ
hybridization of thymus sections with the same probe demon-
strated that TCF-1 was expressed throughout the thymus,
with particularly high levels in the cortex (Fig . 5 b) . In the
same experiment, no signal was obtained with the nonrele-
vant negative control probe S8 (F. Meijlink, unpublished
results) on thymus and spleen sections (data not shown) .
TCF-1 Binds to a Functional Motif in the TCR-cr En-
hancer . Our experiments have demonstrated that TCF-1 con-
trols the T cell-specific activity of the CD3-e enhancer (16;
M . Oosterwegel andH . Clevers, unpublished results) . IfTCF-1
were to play a more general role in T cell differentiation,
it should control transcription ofother T lymphocyte genes .
We therefore compared theTCF-1 footprint with functional
motifs in other TCR and CD3 regulatory sequences (12) .
Homologies to sequences within promoters/enhancers not
known to bind T cell-specific factors or to mediate T
cell-specific transactivation were not included in the com-
parison . Two motifs were thus selected: the 613 element in
the CD3-6 enhancer (25), and the NFa3/TCF-1oe element
in the TCR-ot enhancer (26-29) . The relevant oligonucleo-
tide sequences are aligned in Fig. 6 A . Specific binding of
TCF-1 to the selected oligonucleotide probes was analyzed
by gel retardation and competition with relevant and non-
relevant oligonucleotide probes, performed both on recom-
binant TCF-1 and on crude nuclear extracts .
Fig . 6 B presents the results of a gel retardation experi-
ment performed with the murineTCF-1B fusion protein and
various oligonucleotide probes . Strong binding was observed
to the probes containing theTCF-1 and the NFa3/TCF-lox
motifs (probes MWe1 and MWTCF-1a, respectively; Fig.
6 B, lanes 1 and 4) . Slightly decreased binding was obtained
with a mutant version of MWe1, in which the A residue
located 2 by upstream of theTCR1 footprint was replaced
by a G (MWelA1G ; lane 2) . No binding was observed to
the mutant version ofMWE1, which lacked the TCF-1 motif(MWe1Sac ; lane 3) . A very weak signal was obtained with
theMW6B probe, which contained the 6B motif(MW6B ;
lane 5) . No signal was observed with a probe representing
by43-65 of theCD3-e enhancer (reference 16 ; MWpal, lane
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Figure 4.
￿
Delineation of the DNA-binding do-
main of murine TCF-1 by deletion analysis. The
indicated deletions ofmurine TCF-1Bweregener-
ated as described in Materials and Methods, and
subcloned into pRIT2T to generate protein A fu-
sion proteins . DNA binding was tested by gel
retardation with the cognate probe MWel using
purified fusion proteins (see also Fig . 3 A) . DNA
binding was confined to amino acids 133-237, a
region encompassing the HMG box .
6) . The latter sequence has been predicted to interact with
TCF-la by Waterman and Jones (29, see also Fig . 6 A and
Discussion) .
These observations were extended by competition experi-
Figure 5 .
￿
Murine TCF-1 expression is limited to T lineage cells. (A)
Northern blotting, performed on totalRNA prepared from various tissues
of 2-wk-old BALB/c mice, only detects TCF-1 mRNA in thymus and
spleen samples. The probe used was an NsiI/EcoRI fragment ofpM5 (bp
941-1669 ; see Materials and Methods) . The position of therRNA bands
are indicated with horizontal bars . Equal amounts ofRNA were present
in each lane as judged by examination of the ethidium bromide-stained
gel . Tissues : U, uterus ; E, testis ; A, adrenal gland ; K, kidney; M, muscle ;
I, small intestine ; G, stomach ; S, spleen; T, thymus; L, liver ; F, forebrain ;
H, hindbrain . The nature of the larger TCF-1 mRNA (estimated to be
at least 8 kb) is unknown at present . Prolonged exposure did not reveal
expression ofTCF-1mRNA in tissues other than thymus and spleen (data
not shown) . (B) In situ hybridization with a TCF-1 probe of sections of
spleen (left) and thymus (right) . Spleen : the autoradiographic signals
of labeling were visualized in the periarteriolar lymphocyte sheaths (P)
of the spleen . No signal was observed in the follicles (F), the marginal
zone (M, and the red pulp (90 . Thymus : a signal was obtained
throughout the thymus but was more prominent in cortex (C) than in
medulla (M).ments usingMWel and MWTCF-1a as probes in conjunc-
tion with the TCF-1B fusion protein . Fig. 6 C (left) depicts
results obtained with the MWel probe. Specific competi-
tion was obtainedwith excess unlabeledMWel andMWTCF-
la. No competition was seen with MW56Sac andMWSB.
Essentially identical results were obtained in the reciprocal
experiment (Fig . 6 C, right), where cold excess MWel and
MWTCF-1cr specifically competed for binding to the
MWTCF-1a probe.
Similar experiments were conducted with crude nuclear
extracts ofthehumanT cell line Jurkat . Fig . 6 D (left) demon-
strates that the TCF-1 retarded band (arrow) obtained with
probeMWel could be competed away by cold excessMWe1
and MWTCF-la, but not by MW56Sac, nor by MW6B .
A band with similar migration characteristics was obtained
with the MWTCF-1a probe (Fig. 6 D, right) and probably
represented binding o£ TCF-1 . Again, this band was com-
peted away specifically with cold excess MWel and with
MWTCF-la .
Taken together, these experiments indicated that TCF-1
bound specifically and with comparable affinities to both the
NFa3/TCF-la probe and to the TCF-1 motifof the CD3-e
enhancer. As summarized in Fig . 6 A, no significant binding
was observed to the8B element or to various control probes .
Discussion
The present report describes the isolation and analysis of
murine TCF-1 cDNA clones. Comparison with human TCF-1
revealed a striking degree of homology, in particular in the
COOH-terminal DNA-binding half of this transcription
factor. The two murine clones described in detail were homo-
logues of the human alternative splice forms TCF-1B (16)
and TCF-1D (this report) . The proline-rich alternative exon
identified in clone M2a defined a second position in TCF-1
where alternative splicing can occur, and it stressed the
significance of the proline residues in the NHz-terminal half
of TCF-1.
We presently do not know what the differences in func-
tion are between these alternative splice forms. Based on
analogy to CTF/NF-1 (30), the proline-rich NHz-terminal
segment ofTCF-1 might constitute a transactivation domain.
Extension of the proline-rich domain by an insertional alter-
native exon could enhance or otherwise modulate transacti-
vation as exerted by TCF-1 .
The alternative splices TCF-lA/B/C/D are located near,
but (as shown in the present study)COON terminal to the
DNA-binding domain . Indeed, the methylation interference
footprints of human TCF-1A, -1B, and -1C were indistin-
guishable (16) . Although the alternative COOH termini are
therefore not involved in DNA binding, the complete con-
servation of human and murine TCF-1B and -1D suggests
an important function for these segments . Most likely, the
alternative COOH termini provide surface for interaction
with other proteins directly or indirectlybound to enhancer
sequences.
TCF-1 belongs to a novel family of proteins containing
an 80-amino acid motif, which, based onhomology toHMG
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I proteins, has been termed theHMGbox (16-20) . The only
other protein with proven sequence-specific DNAbinding
characteristics in this family is the polymerase I transcription
factor UBF (17) . UBF contains four HMG boxes, which are
more or less evenly distributed over the length of the mole-
cule. A deletion mutant of UBF containing the first 204
residues and only one of the HMG boxes was still capable
of binding DNA as assessed by binding to a DNA affinity
column; the deletion of 104 additional COOH-terminal amino
acids removed thisHMG box and abrogated DNA binding.
From this experiment, theHMGbox was proposed to con-
stitute a novel protein motif capable of sequence-specific DNA
binding (17) .
The presence of a single HMG box inTCF-1 in conjunc-
tion with its well-defined recognition motif allowed a direct
assessment of the contribution of the TCF-1 HMG box to
sequence-specificDNA binding. Our deletion analysis demon-
strated that a segment of TCF-1, containing theHMG box
plus a short stretch of basic residues directly NHz terminal
to this box, was sufficient to mediate binding. The future
identification ofDNA sequence motifs recognized by other
members of the HMG box family will allow, by means of
sequence comparison and "domain swapping", the iden-
tification ofcritical residues in (and around) the DNA-binding
HMG box domain .
Our recognition of a DNA-binding HMGbox in a poly-
merase II transcription factor has important implications for
other members in this family, in particular for the candidate
mammalian sex-determining gene SRY (18) and for the
S .pombeandN. crassa mating type genes (19, 20) . It is likely
that these genes, like TCF-1, encode polymerase II transcrip-
tion factors ; they could thus govern sexual differentiation (of
mammals, yeast, and fungus, respectively) by direct binding
to regulatory sequences of target genes .
We originally identifiedTCF-1 as aDNA-binding activity
present uniquely in nuclear extracts ofT lineage cells within
a panel of 15 cell lines. The present study extends this obser-
vation : Northern blot analysis ofmouse tissueRNA showed
that TCF-1mRNA expression was confined to tissues oflym-
phoid origin . By in situ hybridization, it was subsequently
found thatTCF-1 was expressed throughout the thymus and
in the T cell areas of the spleen . These results indicate that
TCF-1 expression is indeed T cell specific, and is initiated
early in the T cell differentiation pathway, coinciding with
or possibly preceding expression of the CD3 genes (15) . We
cannot exclude at present that TCF-1 is expressed in other
tissues during embryogenesis, or in cells that occur in rela-
tively low numbers in an adult animal . In situ hybridization
experiments are currently being conducted to investigate these
possibilities.
The expression pattern of TCF-1 is suggestive of its in-
volvement in T cell differentiation . If indeed TCF-1 were a
regulator ofT cell differentiation, it should control the ex-
pression of other genes that build the mature T cell pheno-
type . As demonstrated here, recombinant TCF-1 was capable
ofbinding to a functional motifin theTCRa enhancer, which
has been termed NFc13 in the murine enhancer (26), andTu2
(27, 28) and TCF-la (29) in thehuman enhancer. These motifsFigure 6 .
￿
TCF-1 binds specifically to the NFa3/TCF-la motif of the
TCR-a enhancer (26-29) . (A) Alignment of the sequences of the TCF-1
cognate probe MWel, and various mutants thereof; of the NFa3/TCF-
laMWTCF-la (bp 54-81; reference 27) ; ofthe 6B cognate probeMW6B
(bp 361-384 of the CD3-6 enhancer; reference 25) ; and of MWpal, a se-
quence in the CD3-e enhancer (bp 43-65 ; reference 14) predicted to bind
TCF-la (29) . Binding was assessed in the gel retardation assay as described
in Results. Results with the point mutants ofMWe1 and with MWe178
(M . Oosterwegel andH . Clevers, unpublished results) are not mentioned
elsewhere in the text; they are presented to illustrate the sequence specificity
of TCF-1. See alsoB-D . (B) Gel retardation analysis performedwith recom-
binant murine TCF-1B . Probes are: lane 1, MWel; lane 2, MWeIAIG ;
lane 3, MWe1Sac ; lane 4, MWTCF-1a; lane 5, MWBB ; and lane 6,
MWpal . Strong retardation bands (arrow) were obtained only with the
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TCF-1 cognate probes (lanes 1 and 2) and the NFa3/TCF-la cognate
probe (lane 4) . (C) Competition analysis performed with recombinant mu-
rine TCF-1B and the probes MWei (left) andMWTCF-la (right) . Com-
petition was performed with: lane 1, no competition ; lanes 2 and 3, 10-
and 100-fold excessMWe1; lanes 4 and5, 10- and 100-fold excessMWTCF-
la ; lanes 6 and 7, 10- and 100-fold excess MWe1Sac; lanes 8 and 9, 10-
and 100-fold excessMW6B . Competition was seen only withMWei and
MWTCF-1a. (D) Gel retardation analysis performed with crude nuclear
T cell extracts and the probesMWei (left) andMWTCF-la (right).Com-
petition was performed with : lane 1, no competition ; lane 2, 100-fold
excess MWei ; lane 3, 100-fold excessMWTCF-la; lane 4, 100-fold excess
MW56Sac; and lane 5, 100-fold excess MW5B. The arrow indicates the
position ofthe TCF-1 retardation band. Specific competition occurred again
with cold MWel and MWTCF-la.have been defined by DNaseI footprinting. The NFa3 and
TCF-1a DNA-binding factors are T cell specific and appear
to be homologues of the same factor. TheTO motif prob-
ably represents a composite footprint ofNFa3/TCF-la with
a second T cell-specific DNA-binding protein (28, 29) .
It is highly likely that the TCF-1, as present in T cell nu-
clear extracts, is responsible for the NFa3/TCF-la T
cell-specific DNaseI footprint (27) . Recently, Waterman and
Jones (29) have purified a T cell-specific DNAbinding pro-
tein, TCF-1a, that binds to the NFa3 motif . By analyzing
the affinity ofthis protein for a panel of double-strandedDNA
molecules, they formulated a consensus binding site : CTNTG
(or CANAG) for this protein . Although this consensus ap-
pears too degenerate to describe the sequence preference of
a biologically relevant transcription factor, it fits the TCF-1
motif (AAcAAAG) . The cloning of TCF-la has been an-
nounced (29) ; we anticipate that sequence comparison will
reveal TCF-1a to be identical to human TCF-1 .
TCF-1 thus appears to be involved in the transcriptional
control of at least two T cell genes : CD3-e andTCRa . In
the analysis of a set ofprothymocyte cell lines, TCF-1 expres-
sion was strictly concordant with CD3-e expression (M .
Oosterwegel, A . Kruisbeek, and H . Clevers, unpublished
results) . However, several of the cell lines containing TCF-1
do not express TCR-a . Moreover, the human leukemic T
cell line CCRF-CEM expressesTCF-1 and CD3-e but simi-
larly does not expressTCRa, despite the presence ofa produc-
tively rearranged TCRa locus (16, 31) . This suggests that
TCF-1 expression might be sufficient for CD3-e expression
by differentiating thymocytes, but that TCR-a expression
requires the presence of additional stage-specific transcription
factors.
We propose the existence of a set of genes controlling T
cell differentiation, possibly in a cascade-like fashion . For the
expression of individual structuralT cell genes, different com-
binations of these differentiation control genes act in concert
with more ubiquitous transcription factors . The combinato-
rial activity of a few T cell-specific transcription factors, each
appearing at a particular stage of T cell differentiation, can
thus explain the intricate molecular events that accompany
T cell differentiation.
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